Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
December 17, 2025 Off

Drug Discount Cards Market: Global Strategic Business Report 2025-2030 – Pharmacy Benefit Management (PBM) Integration Expands Reach of Card-Based Savings Networks – ResearchAndMarkets.com

By BusinessWire

DUBLIN–(BUSINESS WIRE)–The “Drug Discount Cards Market – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market…

December 17, 2025 Off

RIS Rx Appoints Stuart McGuigan to Board of Directors

By BusinessWire

IRVINE, Calif.–(BUSINESS WIRE)–RIS Rx, a healthcare technology company offering gross-to-net (GTN) revenue protection and saving more than $1 billion for…

December 17, 2025 Off

DNA Nanobots Secures $3.5 Million Investment to Accelerate Non-Viral Gene Therapy Platform

By BusinessWire

COLUMBUS, Ohio–(BUSINESS WIRE)–DNA Nanobots, a pioneer in self-assembling nanoscale therapeutics, today announced it has secured $3.5 million in funding from…

December 17, 2025 Off

Rhineland-Palatinate Biotech Company MODAG Receives Research Grant Funding from The Michael J. Fox Foundation

By BusinessWire

WENDELSHEIM, Germany–(BUSINESS WIRE)–MODAG GmbH announced it has received a $1 million research grant from The Michael J. Fox Foundation for…

December 17, 2025 Off

Analysis of Guided Therapeutics’ FDA Study Data Reveals Compelling Clinical Need for LuViva

By BusinessWire

PEACHTREE CORNERS, Ga.–(BUSINESS WIRE)–Guided Therapeutics, Inc. (OTCQB: GTHP), the maker of the LuViva Advanced Cervical Scan, a rapid and painless…

December 17, 2025 Off

Galux Announces Research Agreement with Boehringer Ingelheim to Advance AI-Driven Protein Design

By BusinessWire

SEOUL, South Korea–(BUSINESS WIRE)–#AI—Galux, a South Korean biotech pioneering AI-driven protein therapeutics discovery, announced that it has signed a research…

December 17, 2025 Off

ZBiotics® Partners With the Snow Lodge & Après Ski Club in Aspen/Snowmass for Winter 2025–2026

By BusinessWire

First-of-its-kind hospitality partnership brings biotech-backed ‘social wellness’ to one of the world’s premier après destination resorts SAN FRANCISCO–(BUSINESS WIRE)–ZBiotics®, the…

December 17, 2025 Off

Vistagen Announces Topline Results from PALISADE-3 Phase 3 Public Speaking Challenge Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder

By BusinessWire

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared…

December 17, 2025 Off

Kairos Pharma Wins 2025 Clinical Trials Arena Research and Development Excellence Award for Advanced Prostate Cancer

By BusinessWire

Company recognized for advancing ENV‑105, a first‑in‑class resistance‑modulating antibody for metastatic castration‑resistant prostate cancer LOS ANGELES–(BUSINESS WIRE)–Kairos Pharma Ltd. (NYSE…

December 17, 2025 Off

Valink Therapeutics and Nona Biosciences Form Strategic Alliance to Accelerate Novel Biologics Discovery

By BusinessWire

CAMBRIDGE, Mass. & LONDON–(BUSINESS WIRE)–Valink Therapeutics (“Valink”), a private biotechnology company developing next-generation therapeutics with a focus on bispecific antibody-drug…

Posts pagination

Previous 1 … 3 4 5 … 6,215 Next

Popular posts

Medicago, GSK report primary and secondary endpoints with available data met in trial dominated by COVID-19 variants

December 10, 2021 Off

Rare Diseases Treatment Market Analysis and Forecast 2025-2032: A $45.8 Billion Opportunity – Complex Challenges and Unprecedented Opportunities are Emerging – ResearchAndMarkets.com

December 19, 2025 Off
Cosentyx meets the primary endpoints

Cosentyx meets the primary endpoints

June 15, 2015 Off
Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

Adapt Pharma rolls submision to NDA for naloxone-based nasal spray

June 15, 2015 Off
Strensiq in HPP patiens therapy get approval from European Commission

Strensiq in HPP patiens therapy get approval from European Commission

September 13, 2015 Off

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine